Tuesday, September 29, 2026

BTC $83,456 ▼ 0.21%

NewsLive Wire Politics World Markets Digital Assets Technology Sports

FranchisesThe Brief The Big Read The Breakdown Crypto Culture

MoreDeFi & On-Chain U.S. Equities Macro & Rates Research

LIVE

ADA$0.245+0.45%ETH$2,673−0.12%LINK$14.43−1.13%SOL$119.58+0.39%BTC$83,456−0.21%XRP$1.50+0.54%S&P 5007,671−0.17%Nasdaq26,798−0.09%Dow51,350−0.26%RUT2,808−0.35%TNX5.25%+0.29%TYX5.59%+0.59%FVX5.06%−0.10%IRX4.07%+0.20%VIX16.04−0.19%GOLD$4,202.40+0.54%SILVER$61.40+0.40%OIL$89.57+0.21%DXY101.38+0.01%NVDA$227.21−0.72%AAPL$329.40−2.66%TSLA$352.84−1.29%META$738.79+3.24%MSFT$508.96−0.05%AMZN$246.67+0.21%GOOGL$340.92−0.53%Fear & Greed71 — GreedADA$0.245+0.45%ETH$2,673−0.12%LINK$14.43−1.13%SOL$119.58+0.39%BTC$83,456−0.21%XRP$1.50+0.54%S&P 5007,671−0.17%Nasdaq26,798−0.09%Dow51,350−0.26%RUT2,808−0.35%TNX5.25%+0.29%TYX5.59%+0.59%FVX5.06%−0.10%IRX4.07%+0.20%VIX16.04−0.19%GOLD$4,202.40+0.54%SILVER$61.40+0.40%OIL$89.57+0.21%DXY101.38+0.01%NVDA$227.21−0.72%AAPL$329.40−2.66%TSLA$352.84−1.29%META$738.79+3.24%MSFT$508.96−0.05%AMZN$246.67+0.21%GOOGL$340.92−0.53%Fear & Greed71 — Greed

Tag

phase 3 trials

1 article

U.S. Equities1h ago

Eli Lilly's Retatrutide Shows 20.8% Weight Loss at Top Dose; BLA Due Q1 2027

Triple agonist achieves dose-dependent weight reductions up to 49.6 pounds and A1C drops to 5.7% in 40% of patients, clearing path for 2027 market entry.